Status:
UNKNOWN
Cryoablation for Advanced and Refractory Desmoid Tumors
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Desmoid Tumors
Eligibility:
All Genders
18+ years
Brief Summary
Desmoid tumors, also called aggressive fibromatosis, are rare, locally invasive tumors with no potential for metastasis. The incidence is approximately 2 to 4 per million per year in the general popul...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult patient (≥18 years old)
- Having undergone cryoablation for an advanced desmoid tumor refractory to medical treatment
- Having not expressed their opposition, after being informed, to the reuse of their data for the purposes of this research.
- Exclusion criteria:
- Subject who expressed their opposition to participating in the study
- Patient already included in another ongoing study
- Subject under guardianship or curatorship
- Subject under safeguard of justice
Exclusion
Key Trial Info
Start Date :
July 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06113094
Start Date
July 7 2020
End Date
December 31 2023
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Imagerie Interventionnelle - CHU de Strasbourg - France
Strasbourg, France, 67091